Patents by Inventor Kazuya Ofuji

Kazuya Ofuji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Detecting Circulating Tumor Cells
    Publication number: 20180335434
    Abstract: The disclosure relates to a method of detecting circulating tumor cells (CTCs) in a subject, diagnosing cancer, and/or treating a subject in need thereof.
    Type: Application
    Filed: May 16, 2018
    Publication date: November 22, 2018
    Applicants: HITACHI CHEMICAL COMPANY, LTD., National University Corporation UNIVERSITY OF FUKUI
    Inventors: Katsuya Endou, Hisashige Kanbara, Tatsuya Matsunaga, Yasunari Nakamoto, Kazuto Takahashi, Kazuya Ofuji, Katsushi Hiramatsu, Takuto Nosaka
  • Antigen Peptide Derived From the Sequence of Epidermal Growth Factor Receptor Having T790M Point Mutation
    Publication number: 20170049870
    Abstract: The present application relates to an antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation and a pharmaceutical composition for the treatment of cancer comprising the peptide.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 23, 2017
    Applicant: Kanagawa Prefectural Hospital Organization
    Inventors: Tetsuro Sasada, Tetsuya Nakatsura, Kazuya Ofuji
  • Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation
    Patent number: 9505824
    Abstract: The present application relates to an antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation and a pharmaceutical composition for the treatment of cancer comprising the peptide.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: November 29, 2016
    Assignee: Kanagawa Prefectural Hospital Organization
    Inventors: Tetsuro Sasada, Tetsuya Nakatsura, Kazuya Ofuji
  • Antigen Peptide Originated From T790M Point-Mutated Sequence of Epidermal Growth Factor Receptor
    Publication number: 20150218248
    Abstract: The present application relates to an antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation and a pharmaceutical composition for the treatment of cancer comprising the peptide.
    Type: Application
    Filed: August 8, 2013
    Publication date: August 6, 2015
    Applicant: Kanagawa Prefectural Hospital Organization
    Inventors: Tetsuro Sasada, Tetsuya Nakatsura, Kazuya Ofuji